UBS Group upgraded the stock rating for Sartorius Stedim Biotech S.A. on August 1, 2026, and MarketBeat reported the average rating.
1 report, 1 independent
Updated Aug 1
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
UBS Group upgraded the stock rating for Sartorius Stedim Biotech S.A. on August 1, 2026, and MarketBeat reported the average rating.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
MarketBeat
American personal finance blog
Related events
- MarketBeat reported an average stock rating for Superior Group of Companies.
- MarketBeat reported recent stock ratings for Innovative Solutions and Support, Inc. and TechPrecision Corporation.
- Jefferies Financial Group raised its rating on Bausch Health Companies Inc. to hold, while MarketBeat reported the average stock rating.
- Needham & Company downgraded Heron Therapeutics stock rating, while MarketBeat provided average stock rating data.
- MarketBeat reported average stock rating for I-Mab on September 9, 2026.